Sandoz's Remodulin Generic Infringes UTC Patent, Judge Says
A New Jersey federal judge on Friday found that Sandoz Inc.'s proposed generic version of the hypertension drug Remodulin infringes one of two United Therapeutics Corp. patents, rejecting Sandoz's contention that...To view the full article, register now.
Already a subscriber? Click here to view full article